MTEM(Delisted)
Molecular TemplatesยทNASDAQ
--
--(--)
MTEM fundamentals
Molecular Templates (MTEM) released its earnings on Mar 28, 2018: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Mar 28, 2018
EPS
Revenue
Revenue & Expenses
MTEM has released its 2024 Q2 earnings report, with revenue of 572.00K, reflecting a YoY change of -91.67%, and net profit of -8.10M, showing a YoY change of 25.50%. The Sankey diagram below clearly presents MTEM's revenue sources and cost distribution.
Key Indicators
Molecular Templates (MTEM) key financial stats and ratios, covering profitability, financial health, and leverage.
Molecular Templates (MTEM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Molecular Templates (MTEM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Molecular Templates (MTEM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Molecular Templates (MTEM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Molecular Templates (MTEM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
